Absorption and metabolism of milk thistle flavanolignans in humans

Phytomedicine

Volumn 20, Issue 1, 2012, Pages 40-46

  Calani, Luca ^a   Brighenti, Furio ^a   Bruni, Renato ^a   Del Rio, Daniele ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Bioavailability; Flavanolignans; Mass spectrometry; Silybum marianum; Silymarin; Urinary metabolites

Indexed keywords

SILYMARIN;

ADULT; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; SILYBUM MARIANUM;

ADULT; BIOLOGICAL AVAILABILITY; FEMALE; GLUCURONIDES; HUMANS; INTESTINAL ABSORPTION; LIVER; MALE; MILK THISTLE; PLANT EXTRACTS; SILYMARIN; YOUNG ADULT;

SILYBUM MARIANUM;

EID: 84870460057     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.09.004     Document Type: Article

References (30)

1. A. Crozier, D. Del Rio, and M.N. Clifford Bioavailability of dietary flavonoids and phenolic compounds Molecular Aspects of Medicine 31 2010 446 467
2. A. Crozier, I.B. Jaganath, and M.N. Clifford Dietary phenolics: chemistry, bioavailability and effects on health Natural Products Reports 26 2009 1001 1043
3. D. Del Rio, L. Calani, C. Cordero, S. Salvatore, N. Pellegrini, and F. Brighenti Bioavailability and catabolism of green tea flavan-3-ols in humans Nutrition 26 2010 1110 1116
4. J.L. Donovan, C. Manach, R.M. Fauks, R.M. Faulks, and P.A. Kroon Absorption and metabolism of dietary plant secondary metabolites A. Crozier, M.N. Clifford, H. Ashihara, Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet 1st edition 2006 Blackwell Publishing Oxford, UK 303 351
5. P. Ferenci, B. Dragosics, H. Dittrich, H. Frank, L. Benda, H. Lochs, S. Meryn, W. Base, and B. Schneider Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver Journal of Hepatology 9 2009 105 113
6. P. Ferenci, T.M. Scherzer, H. Kerschner, K. Rutter, S. Beinhardt, H. Hofer, M. Schöniger-Hekele, H. Holzmann, and P. Steindl-Munda Silybinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy Gastroenterology 135 2008 1561 1567
7. R.L. Hawke, S.J. Schrieber, T.A. Soule, Z. Wen, P.C. Smith, K.R. Reddy, A.S. Wahed, S.H. Belle, N.H. Afdhal, V.J. Navarro, J. Berman, Q.Y. Liu, E. Doo, and M.W. Fried Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C Journal of Clinical Pharmacology 50 2010 434 449
8. S.M. Henning, Y. Niu, Y. Liu, N.H. Lee, Y. Hara, G.D. Thames, R.R. Minutti, C.L. Carpenter, H. Wang, and D. Heber Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals The Journal of Nutritional Biochemistry 16 2005 610 616 (Pubitemid 41338373)
9. C. Hoh, D. Boocock, T. Marczylo, R. Singh, D.P. Berry, A.R. Dennison, D. Hemingway, A. Miller, K. West, S. Euden, G. Garcea, P.B. Farmer, W.P. Steward, and A.J. Gescher Pilot study of oral silybinin, a putative chemopreventive agent, in colorectal cancer patients: silybinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences Clinical Cancer Research 12 2006 2944 2950
10. C.S. Hoh, D.J. Boocock, T.H. Marczylo, V.A. Brown, H. Cai, W.P. Steward, D.P. Berry, and A.J. Gescher Quantitation of silybinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites Journal of Agricultural and Food Chemistry 55 2007 2532 2535 (Pubitemid 46623745)
11. B.P. Jacobs, C. Dennehy, G. Ramirez, J. Sapp, and V.A. Lawrence Milk thistle for the treatment of liver disease: a systematic review and meta-analysis American Journal of Medicine 113 2002 506 515 (Pubitemid 35335804)
12. J.I. Lee, B.H. Hsu, D. Wu, and J.S. Barrett Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry Journal of Chromatography A 1116 2006 57 68 (Pubitemid 44287926)
13. M.J. Lee, P. Maliakal, L. Chen, X. Meng, F.Y. Bondoc, S. Prabhu, G. Lambert, S. Mohr, and C.S. Yang Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability Cancer Epidemiology, Biomarkers and Prevention 11 2002 1025 1032 (Pubitemid 35192653)
14. M.I. Lucena, R.J. Andrade, J.P. de la Cruz, M. Rodriguez-Mendizabal, E. Blanco, and F. Sánchez de la Cuesta Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study International Journal of Clinical Pharmacology and Therapeutics 40 2002 2 8 (Pubitemid 34100788)
15. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Rémésy Bioavailability and bioefficacy of polyphenols in humans. I: review of 97 bioavailability studies The American Journal of Clinical Nutrition 81 Suppl. 1 2005 S230 S242
16. K.E. Mayer, R.P. Myers, and S.S. Lee Silymarin treatment of viral hepatitis: a systematic review Journal of Viral Hepatitis 12 2005 559 567 (Pubitemid 41532486)
17. C. Morishima, M.C. Shuhart, C.C. Wang, D.M. Paschal, M.C. Apodaca, Y. Liu, D.D. Sloan, T.N. Graf, N.H. Oberlies, D.Y. Lee, K.R. Jerome, and S.J. Polyak Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection Gastroenterology 138 2010 671-681, 681.e1-681.e2
18. A. Parés, R. Planas, M. Torres, J. Caballería, J.M. Viver, D. Acero, J. Panés, J. Rigau, J. Santos, and J. Rodés Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial Journal of Hepatology 28 1998 615 621 (Pubitemid 28167999)
19. J.K. Prasain, and S. Barnes Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospects Molecular Pharmaceutics 4 2007 846 864
20. A. Rambaldi, B.P. Jacobs, and C. Gluud Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases Cochrane Database of Systematic Reviews 17 2007 CD003620
21. A. Rambaldi, B.P. Jacobs, G. Iaquinto, and C. Gluud Milk thistle for alcoholic and/or hepatitis B or C liver diseases - a systematic Cochrane hepato-biliary group review with meta-analyses of randomized clinical trials American Journal of Gastroenterology 100 2005 2583 2591
22. C. Saliou, B. Rihn, J. Cillard, T. Okamoto, and L. Packer Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways FEBS Letters 440 1998 8 12 (Pubitemid 28558724)
23. M. Shibano, A.S. Lin, H. Itokawa, and K.H. Lee Separation and characterization of active flavonolignans of Silybum marianum by liquid chromatography connected with hybrid ion-trap and time-of-flight mass spectrometry (LC-MS/IT-TOF) Journal of Natural Products 70 2007 1424 1428 (Pubitemid 47584581)
24. A. Stalmach, S. Troufflard, M. Serafini, and A. Crozier Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans Molecular Nutrition and Food Research 53 Suppl. 1 2009 S44 S53
25. D.B. Strader, B.R. Bacon, K.L. Lindsay, D.R. La Brecque, T. Morgan, E.C. Wright, J. Allen, M.F. Khokar, J.H. Hoofnagle, and L.B. Seeff Use of complementary and alternative medicine in patients with liver disease American Journal of Gastroenterology 97 2002 2391 2397
26. M. Trappoliere, A. Caligiuri, M. Schmid, C. Bertolani, P. Failli, F. Vizzutti, E. Novo, C. di Manzano, F. Marra, C. Loguercio, and M. Pinzani Silybin, a component of silymarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells Journal of Hepatology 50 2009 1102 1111
27. M. Velussi, A.M. Cernigoi, A. De Monte, F. Dapas, C. Caffau, and M. Zilli Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients Journal of Hepatology 26 1997 871 879 (Pubitemid 27145712)
28. J. Wagoner, A. Negash, O.J. Kane, L.E. Martinez, Y. Nahmias, N. Bourne, D.M. Owen, J. Grove, C. Brimacombe, J.A. McKeating, E.I. Pécheur, T.N. Graf, N.H. Oberlies, V. Lohmann, F. Cao, J.E. Tavis, and S.J. Polyak Multiple effects of silymarin on the hepatitis C virus lifecycle Hepatology 51 2010 1912 1921
29. K. Wang, H. Zhang, L. Shen, Q. Du, and J. Li Rapid separation and characterization of active flavonolignans of Silybum marianum by ultra-performance liquid chromatography coupled with electrospray tandem mass spectrometry Journal of Pharmaceutical and Biomedical Analysis 53 2010 1053 1057
30. Z. Wen, T.E. Dumas, S.J. Schrieber, R.L. Hawke, M.W. Fried, and P.C. Smith Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract Drug Metabolism and Disposition: The Biological Fate of Chemicals 36 2008 65 72